Physician

Radu Zidarescu, MD

According to 2025 Medicare claims, Radu Zidarescu, MD (NPI: 1073582094) practices pulmonary disease in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-1095. Zidarescu is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Zidarescu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 558 traditional Medicare patients, billed 2,735 HCPCS/CPT codes, and received $149,921 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 7,868 prescription claims across 647 beneficiaries totaling $1,559,223 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,455 claims. Open Payments data shows 23 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $275,556 to $149,921. In contrast, Part D prescription costs have risen steadily, from $689,465 to $1,559,223. For DME billing, reported payments rose steadily, from $81,546 to $98,023.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	651	6,551	$275,556
2016	620	6,995	$284,104
2017	640	6,654	$267,954
2018	663	5,770	$243,136
2019	647	5,224	$237,670
2020	588	4,577	$209,292
2021	583	2,190	$155,979
2022	502	1,763	$123,861
2023	538	2,015	$138,234
2024	558	2,735	$149,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	349	9,013	$689,465
2016	357	8,453	$772,606
2017	393	8,625	$820,128
2018	445	8,637	$916,986
2019	484	8,215	$1,006,327
2020	498	8,344	$1,194,700
2021	485	7,742	$1,266,342
2022	477	6,952	$1,159,043
2023	504	6,978	$1,148,392
2024	647	7,868	$1,559,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	303	1,512	$92,631
2016	249	1,337	$50,705
2017	226	1,236	$40,975
2018	245	1,288	$51,788
2019	335	1,567	$55,679
2020	258	1,606	$107,071
2021	338	1,765	$105,193
2022	363	1,673	$106,323
2023	296	1,345	$89,373
2024	318	1,455	$124,268

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	72	79	$130
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	78	193	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	240	376	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	247	355	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	95	189	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	267	11,010	$234,186
Spiriva Respimat	Tiotropium Bromide	270	10,888	$186,488
Dupixent Pen	Dupilumab	36	924	$129,581
Eliquis	Apixaban	105	4,973	$96,367
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	124	4,310	$86,015

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	28	$28,797
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	28	$23,925
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	40	266	$21,767
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	11	$19,094
E1392	Portable oxygen concentrator, rental	Y	16	99	$3,486

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$417	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Radu Zidarescu, MD?

Tedicare shows public-source Medicare data for Radu Zidarescu, MD (NPI 1073582094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Radu Zidarescu, MD have ACO affiliation data?

Radu Zidarescu, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Radu Zidarescu, MD?

Radu Zidarescu, MD is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Radu Zidarescu, MD have Open Payments data?

Radu Zidarescu, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.